Global Peanut Allergy Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Peanut Allergy Therapeutics market size will reach 1,723.06 Million USD in 2025 and is projected to reach 7,926.21 Million USD by 2032, with a CAGR of 24.36% (2025-2032). Notably, the China Peanut Allergy Therapeutics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Peanut allergy therapeutics refer to medical treatments and interventions developed to address peanut allergies, which are potentially life-threatening immune reactions to peanuts. These therapeutics aim to reduce the severity of allergic reactions or, in some cases, desensitize individuals with peanut allergies, allowing them to tolerate peanuts without experiencing severe symptoms. Immunotherapy, such as oral immunotherapy (OIT) and sublingual immunotherapy (SLIT), is a common approach, where individuals are gradually exposed to small, controlled amounts of peanut allergen to build tolerance. In some cases, biologics like monoclonal antibodies that target specific immune pathways involved in allergic responses are also being explored as treatment options. Peanut allergy therapeutics are critical for improving the quality of life and safety of individuals with peanut allergies by potentially reducing the risk of accidental exposure and severe allergic reactions.
The major global suppliers of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, Johnson & Johnson, Perrigo, GSK, Kaleo, Amneal Pharma, ALK Abello, Aimmune Therapeutics, HUAPONT Pharm, Sanofi, ASIT Biotech, Allergy Therapeutics, DBV Technologies, HAL Allergy, Intrommune Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peanut Allergy Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peanut Allergy Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Peanut Allergy Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peanut Allergy Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peanut Allergy Therapeutics Include:
Mylan
Bayer
UCB Pharma
Johnson & Johnson
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Sanofi
ASIT Biotech
Allergy Therapeutics
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Peanut Allergy Therapeutics Product Segment Include:
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Peanut Allergy Therapeutics Product Application Include:
Adults
Children
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Peanut Allergy Therapeutics Industry PESTEL Analysis
Chapter 3: Global Peanut Allergy Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Peanut Allergy Therapeutics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Peanut Allergy Therapeutics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Peanut Allergy Therapeutics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Peanut Allergy Therapeutics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Peanut Allergy Therapeutics market size will reach 1,723.06 Million USD in 2025 and is projected to reach 7,926.21 Million USD by 2032, with a CAGR of 24.36% (2025-2032). Notably, the China Peanut Allergy Therapeutics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Peanut allergy therapeutics refer to medical treatments and interventions developed to address peanut allergies, which are potentially life-threatening immune reactions to peanuts. These therapeutics aim to reduce the severity of allergic reactions or, in some cases, desensitize individuals with peanut allergies, allowing them to tolerate peanuts without experiencing severe symptoms. Immunotherapy, such as oral immunotherapy (OIT) and sublingual immunotherapy (SLIT), is a common approach, where individuals are gradually exposed to small, controlled amounts of peanut allergen to build tolerance. In some cases, biologics like monoclonal antibodies that target specific immune pathways involved in allergic responses are also being explored as treatment options. Peanut allergy therapeutics are critical for improving the quality of life and safety of individuals with peanut allergies by potentially reducing the risk of accidental exposure and severe allergic reactions.
The major global suppliers of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, Johnson & Johnson, Perrigo, GSK, Kaleo, Amneal Pharma, ALK Abello, Aimmune Therapeutics, HUAPONT Pharm, Sanofi, ASIT Biotech, Allergy Therapeutics, DBV Technologies, HAL Allergy, Intrommune Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peanut Allergy Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peanut Allergy Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Peanut Allergy Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peanut Allergy Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peanut Allergy Therapeutics Include:
Mylan
Bayer
UCB Pharma
Johnson & Johnson
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Sanofi
ASIT Biotech
Allergy Therapeutics
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Peanut Allergy Therapeutics Product Segment Include:
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Peanut Allergy Therapeutics Product Application Include:
Adults
Children
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Peanut Allergy Therapeutics Industry PESTEL Analysis
Chapter 3: Global Peanut Allergy Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Peanut Allergy Therapeutics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Peanut Allergy Therapeutics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Peanut Allergy Therapeutics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Peanut Allergy Therapeutics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Peanut Allergy Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Peanut Allergy Therapeutics Product by Type
- 1.2.1 Epinephrine Injection
- 1.2.2 Antihistamines
- 1.2.3 Oral Immunotherapy
- 1.2.4 Other
- 1.3 Peanut Allergy Therapeutics Product by Application
- 1.3.1 Adults
- 1.3.2 Children
- 1.4 Global Peanut Allergy Therapeutics Market Size Analysis (2020-2032)
- 1.5 Peanut Allergy Therapeutics Market Development Status and Trends
- 1.5.1 Peanut Allergy Therapeutics Industry Development Status Analysis
- 1.5.2 Peanut Allergy Therapeutics Industry Development Trends Analysis
- 2 Peanut Allergy Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Peanut Allergy Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Peanut Allergy Therapeutics Market Analysis by Country
- 4.1 Global Peanut Allergy Therapeutics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Peanut Allergy Therapeutics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Peanut Allergy Therapeutics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.5 China Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.6 France Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.14 India Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Peanut Allergy Therapeutics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Peanut Allergy Therapeutics Market Revenue by Key Suppliers (2021-2025)
- 5.2 Peanut Allergy Therapeutics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Peanut Allergy Therapeutics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Peanut Allergy Therapeutics Market Analysis by Type
- 6.1 Global Peanut Allergy Therapeutics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Peanut Allergy Therapeutics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Mylan
- 7.1.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Mylan Peanut Allergy Therapeutics Product Portfolio
- 7.1.3 Mylan Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Bayer
- 7.2.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Bayer Peanut Allergy Therapeutics Product Portfolio
- 7.2.3 Bayer Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 UCB Pharma
- 7.3.1 UCB Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
- 7.3.3 UCB Pharma Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Johnson & Johnson
- 7.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Johnson & Johnson Peanut Allergy Therapeutics Product Portfolio
- 7.4.3 Johnson & Johnson Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Perrigo
- 7.5.1 Perrigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Perrigo Peanut Allergy Therapeutics Product Portfolio
- 7.5.3 Perrigo Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 GSK
- 7.6.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 GSK Peanut Allergy Therapeutics Product Portfolio
- 7.6.3 GSK Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Kaleo
- 7.7.1 Kaleo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Kaleo Peanut Allergy Therapeutics Product Portfolio
- 7.7.3 Kaleo Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Amneal Pharma
- 7.8.1 Amneal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
- 7.8.3 Amneal Pharma Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 ALK Abello
- 7.9.1 ALK Abello Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 ALK Abello Peanut Allergy Therapeutics Product Portfolio
- 7.9.3 ALK Abello Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Aimmune Therapeutics
- 7.10.1 Aimmune Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 7.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 HUAPONT Pharm
- 7.11.1 HUAPONT Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
- 7.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Sanofi
- 7.12.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Sanofi Peanut Allergy Therapeutics Product Portfolio
- 7.12.3 Sanofi Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 ASIT Biotech
- 7.13.1 ASIT Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
- 7.13.3 ASIT Biotech Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Allergy Therapeutics
- 7.14.1 Allergy Therapeutics Basi
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
